Table 4.
Treatment-related enhancement of a cell-mediated immune response in the spleens of experimental rats.
| Variable | Percentage of CD3+ T cell in gate | Percentage of CD4+ T cell in gate | Percentage of CD8+ T cell in gate | CD4/CD8 Ratio | ||||
|---|---|---|---|---|---|---|---|---|
| Median (%) | P25 ~P75 | Median (%) | P25 ~P75 | Median (%) | P25 ~P75 | Median (%) | P25 ~P75 | |
| Sham | 43.37 | 38.62~50.63 | 57.04 | 56.72~59.17 | 33.83 | 31.66~35.50 | 1.690 | 1.606~1.870 |
| Control | 36.62 | 32.03~42.88 | 57.11 | 56.81~58.22 | 35.09 | 30.47~37.82 | 1.628 | 1.518~1.899 |
| Low-dose | 40.13 | 29.27~45.59 | 64.00* | 54.26~71.09 | 25.05* | 19.28~28.78 | 2.560* | 1.894~3.798 |
| High-dose | 42.16 | 39.50~46.68 | 64.26* | 61.82~68.83 | 22.50* | 19.13~23.80 | 2.955* | 2.610~3.602 |
*Mean P < 0.05, when compared with control group.